•
US-based Boston Scientific Corporation (NYSE: BSX) has announced a partnership with Japan-based Omron Healthcare at the 5th China International Import Expo (CIIE). The collaboration is focused on enhancing the management of cardiovascular and cerebrovascular diseases, particularly atrial fibrillation. The two companies will integrate their product and resource advantages to bolster…
•
The 5th China International Import Expo (CIIE) saw the announcement of a partnership between Takeda Pharmaceutical Co., Ltd (TYO: 4502) and US firms Amazon Web Services (AWS) and Accenture. The collaboration also marks the initiation of “TakedaSpark+”, an innovation incubation platform launched by the Japan-based firm in 2021. Through this…
•
China-based Betta Pharmaceuticals Co., Ltd (SHE: 300558) has announced the summary report of a Phase II/III study for its third-generation epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) BPI-D0316. The study evaluated the drug as a first-line treatment for naïve locally advanced or metastatic non-small cell lung cancer (NSCLC) with EGFR…
•
China-based biotech BeiGene Inc. (HKG: 6160, SHA: 688235, NASDAQ: BGNE) released its Q3 2022 earnings report, showing robust growth with revenues reaching USD 387.6 million, an 88% year-on-year (YOY) expansion. Sales from products totaled USD 349.5 million during the period, up 82% YOY, driven primarily by Brukinsa (zanubrutinib) and the…
•
A strategic partnership between China-based Shandong Xinhua Pharmaceutical Co., Ltd (HKG: 0719) and Bayer Consumer Care AG was unveiled at the 5th China International Import Expo (CIIE) meeting. The collaboration aims to leverage the respective strengths of both companies to construct new mechanisms of cooperation in the medical and healthcare…
•
US-based Medtronic Inc. (NYSE: MDT) has announced a partnership with Shanghai JiaHui International Hospital, unveiled at the 5th China International Import Expo (CIIE) held this week. The collaboration aims to enhance patient services, upgrade supply chains, and implement clinical solutions, among other initiatives. Financial details of the partnership were not…
•
ChainGen Bio, a Shanghai-based developer of X-oligo conjugates (XOCs), has reportedly raised RMB 45 million (USD 6.2 million) in an angel financing round co-led by Matrix Partners and Frees Fund. The proceeds will be used to advance pipeline research and development, patent layout, and company operations, including laboratory platform construction.…
•
Yibao Technology Co., Ltd, a Shanghai-based service provider for city-level supplementary commercial insurance (“Huiminbao”) schemes, has reportedly raised an undisclosed amount in a Series A+ financing round. The round was led by China Resources Pharmaceutical Group Ltd, China Resources Medicine Commercial Holdings Ltd, and China Resources Sanjiu Medical & Pharmaceutical…
•
China-based Haisco Pharmaceutical Group Co., Ltd (SHE: 002653) has announced that a market approval filing for its drug candidate HSK16149, intended for the treatment of diabetic peripheral neuropathic pain (DPNP), has been accepted for review by the National Medical Products Administration (NMPA). HSK16149 is an in-house Category 1 drug being…
•
Cowell Health has announced a partnership with UK-based AstraZeneca (AZ, NASDAQ: AZN) at the 5th China International Import Expo (CIIE), aimed at enhancing precision whole disease course management services for cancer patients. The collaboration focuses on improving accessibility to novel cancer treatments and other health services, particularly for patients with…
•
China’s Liaoning Chengda Biotechnology Co., Ltd (SHA: 688739) has announced that it has received clinical clearance from the National Medical Products Administration (NMPA) for its ACYW135 meningococcal polysaccharide conjugate vaccine. The vaccine is designed to prevent epidemic cerebrospinal meningitis caused by Neisseria meningitidis of groups A, C, Y, and W135.…
•
China-based Lee’s Pharmaceutical Holdings Ltd (HKG: 0950) spin-off Zhaoke Ophthalmology Ltd (HKG: 6622) has announced the enrollment of the first patients for its ZKY001 in a Phase II clinical study in transepithelial photorefractive keratectomy (TPRK). The study will enroll 120 patients across 10 centers. Additionally, a separate Phase II clinical…
•
The Center for Drug Evaluation (CDE) has released the “New Drug Benefit-Risk Assessment Technical Guidelines,” which are open for public feedback for a one-month period. These guidelines are designed to determine whether a drug’s expected benefit outweighs the potential risks for the proposed indication. Draft Proposal BackgroundThe draft proposal is…
•
China-based Lee’s Pharmaceutical Holdings Ltd (HKG: 0950) spin-off Zhaoke Ophthalmology Ltd (HKG: 6622) has announced a licensing agreement with South Korea’s C&V Tech, a glaucoma device firm. The agreement grants Zhaoke exclusive rights for registration, import, promotion, distribution, marketing, and sales of C&V Tech’s TONO-i tonometer in Greater China. No…
•
The Center for Drug Evaluation (CDE) has released the “New Drug Benefit-Risk Assessment Technical Guidelines,” soliciting public feedback for a one-month period. The guidelines aim to determine whether a drug’s expected benefit outweighs the potential risks for the proposed indication. Draft Proposal BackgroundThe draft proposal is based on several key…
•
Insilico Medicine, an artificial intelligence (AI)-driven drug discovery company based in Hong Kong, has announced a multi-year, multi-target strategic research collaboration with French pharmaceutical major Sanofi. The partnership aims to leverage Insilico Medicine’s AI platform, Pharma.AI, to advance drug development candidates for up to six new targets. Collaboration DetailsUnder the…
•
The Center for Drug Evaluation (CDE) has released a Technical Guidelines document focused on “Clinical R&D of Anti-tumor Drugs for Children.” The document is open for public feedback for a one-month period, aiming to gather insights and suggestions from stakeholders in the field of pediatric oncology. Pediatric vs. Adult Anti-tumor…
•
The 5th China International Import Expo (CIIE) saw the announcement of a partnership between US-based Pfizer (NYSE: PFE), the Chinese Alliance for Rare Disease (CARD), China Social Assistance Foundation (CSAF), and Ping An Healthcare and Technology Co., Ltd (HKG: 1833), also known as PingAn Good Doctor. The collaboration aims to…
•
The 5th China International Import Expo (CIIE) saw US-based Pfizer’s China unit announce a partnership with China-based Alibaba Health Information Technology Ltd (HKG: 0241). The collaboration aims to explore an innovative disease education model, though no financial details were disclosed. Partnership ObjectivesThe partnership between Pfizer’s China unit and Alibaba Health…
•
China-based Adicon Holdings Limited has announced a strategic partnership with US-based Illumina (NASDAQ: ILMN) at the 5th China International Import Expo (CIIE). The collaboration targets the central laboratory program, aiming to enhance clinical studies and drug development plans centered around TruSight Oncology 500 (TSO 500), a research-only pan-cancer detection assay.…